Imlifidase as novel treatment strategy in anti-neutrophil cytoplasmic antibody–induced pulmonary-renal syndrome

Tools

Item Type:	Letter
Title:	Imlifidase as novel treatment strategy in anti-neutrophil cytoplasmic antibody–induced pulmonary-renal syndrome
Creators Name:	Enghard, P., Zickler, D., Sonnemann, J., Schneider, W., Lurje, G., Elezkurtaj, S., Eckardt, K.U. and Schreiber, A.
Keywords:	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Antineutrophil Cytoplasmic Antibodies, Glomerulonephritis, Hemorrhage, Lung Diseases
Source:	Kidney International
ISSN:	0085-2538
Publisher:	Elsevier
Volume:	100
Number:	6
Page Range:	1344-1345
Date:	December 2021
Official Publication:	https://doi.org/10.1016/j.kint.2021.09.020
PubMed:	View item in PubMed

Repository Staff Only: item control page